EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

WDR5‐H3K4me3 Epigenetic Axis Promotes TRMT6‐Dependent tRNA M 1 A Modification to Facilitate Triple‐Negative Breast Cancer Progression by Suppressing Ferroptosis

Yuqing Lei, Xue Wang, Jiahe Liu, Zixu Niu, Jiaqi Hua, Qian Guo, Dan Du, Yuanchang Zhu, Fucheng He, Mingxia Zhou, Hongle Li, Jing He und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202513277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuqing Lei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Ferroptosis, Epigenesis, Genetic, tRNA Methyltransferases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan, Henan Provincial Key Scientific and Technological Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N 1 ‐methyladenosine (m 1 A) modification widely occurs in various RNAs, yet its pathophysiological function in tumorigenesis remains poorly understood. Notably, the expression and biological roles of tRNA m 1 A methyltransferase 6 noncatalytic subunit (TRMT6) in breast cancer, particularly in triple‐negative breast cancer (TNBC), are unknown. Herein, it is demonstrated that TRMT6 is markedly elevated in TNBC, due to the H3K4me3 methylation modification occurring at the promoter region to enhance transcription. Through integrated analyses of m 1 A tRNA methylated RNA immunoprecipitation sequencing, ribosome profiling sequencing, RNA sequencing and data‐independent acquisition mass spectrometry, ferritin heavy chain 1 (FTH1) is identified as a downstream target of TRMT6. Mechanistically, it is found that TRMT6 is responsible for the formation of m 1 A methylation on tRNAs, which increases the translation efficiency of FTH1. Besides, TRMT6 promotes ferritin light chain (FTL) expression at both transcriptional and translational levels, further reinforcing its role in iron metabolism. TRMT6 regulates the malignant progression of TNBC by modulating ferroptosis in tumor cells. Conclusively, the findings indicate that histone methylation‐driven TRMT6 is crucial for the translation of FTH1 and FTL, which bridges the understanding of m 1 A tRNA modification and ferroptosis. These results highlight TRMT6 as a novel potential therapeutic target for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsFerroptosisEpigenesis, GenetictRNA MethyltransferasesHistonesRNA, TransferHistone-Lysine N-MethyltransferaseHumansFemaleCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticMethylationFerritinsOxidoreductases

Stichwörter der Autor:innen

N1‐methyladenosineTNBCTRMT6WDR5ferroptosis

Substanzen

tRNA MethyltransferasesHistonesRNA, TransferHistone-Lysine N-Methyltransferasehistone H3 trimethyl Lys4FTH1 protein, humanFerritinsOxidoreductases

Autor:innen und Institutionen

  • Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, China.
  • Department of Medical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Henan
  • Henan Provincial Key Scientific and Technological Project
  • Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Project

Zitieren

APA

Lei, Y., Wang, X., Liu, J., Niu, Z., Hua, J., Guo, Q., Du, D., Zhu, Y., He, F., Zhou, M., Li, H., He, J., & Li, J. (2026). WDR5‐H3K4me3 Epigenetic Axis Promotes TRMT6‐Dependent tRNA M 1 A Modification to Facilitate Triple‐Negative Breast Cancer Progression by Suppressing Ferroptosis. Advanced Science. https://doi.org/10.1002/advs.202513277

Vancouver

Lei Y, Wang X, Liu J, Niu Z, Hua J, Guo Q, et al. WDR5‐H3K4me3 Epigenetic Axis Promotes TRMT6‐Dependent tRNA M 1 A Modification to Facilitate Triple‐Negative Breast Cancer Progression by Suppressing Ferroptosis. Advanced Science. 2026. doi:10.1002/advs.202513277

BibTeX
@article{Lei2026,
  author = {Lei, Yuqing and Wang, Xue and Liu, Jiahe and Niu, Zixu and Hua, Jiaqi and Guo, Qian and Du, Dan and Zhu, Yuanchang and He, Fucheng and Zhou, Mingxia and Li, Hongle and He, Jing and Li, Jun},
  title = {WDR5‐H3K4me3 Epigenetic Axis Promotes TRMT6‐Dependent tRNA M 1 A Modification to Facilitate Triple‐Negative Breast Cancer Progression by Suppressing Ferroptosis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202513277}
}
Kostenlos starten →